Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study
Initiation or switching to IDegAsp led to improvement in glycaemic control in real-world population of Indian adults with T2D. This was accompanied by a numerical reduction in resource utilization and patient-reported hypoglycaemia. <b>Clinical trial registration:</b> NCT04042441.
Authors
- Pankaj Aneja
- Manash Baruah (ORCID: https://orcid.org/0000-0003-3064-2605)
- Manjunatha Revanna
- Mathew John (ORCID: https://orcid.org/0000-0002-6435-7995)
- Sanjay Shah (ORCID: https://orcid.org/0000-0001-5519-4154)
- Muzammil Khan A Pathan
- Prasad Gurumallappa Mahadev
- Deepaklal Chhabrai Madhavdas
- Manu Chandrappa
- Ajay Aggarwal
- Abhijit Bhograj
- Shailesh Pitale
- Ritesh Kumar Agrawala
- Kiran P. Singh
Institutions
- Novo Nordisk (Denmark) (DK)
- CARE Hospitals (IN)
- Max Healthcare (IN)
- India Diabetes Research Foundation (IN)
- Fortis Hospital (IN)
- Nethradhama Superspeciality Eye Hospital (IN)
- Fortis Hospital (IN)
- Novo Nordisk (India) (IN)
- AMRI Hospitals (IN)
- Columbia Asia (IN)
Publication Details
- Journal
- Journal of Family Medicine and Primary Care
- Published
- 2024-09-01
- DOI
- https://doi.org/10.4103/jfmpc.jfmpc_1401_23
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.36